CYTEXORTHO

CytexOrtho is a pre-clinical stage medical device company working to advance orthopaedic treatment options for cartilage repair. Our purpose is to leverage the pioneering tissue regeneration work of Dr. Farshid Guilak, Dr. Bradley Estes, and Dr. Frank Moutos. Dr. Guilak, formerly at Duke University and now at Washington University in St. Louis, is Executive Chairman of Cytex and continues to lend his guidance and advice to the company. Dr. Estes serves as CEO and Dr. Moutos as VP of Technology Development... CytexOrtho has a world-renowned Clinical Advisory Board (CAB) consisting of experts in orthopedic surgery and imaging. Input from the CAB has been instrumental for CytexOrtho to plan for our clinical trial, and will keep CytexOrtho focused on the very real challenges these doctors face in treating their patients facing early joint disease... Osteoarthritis is a leading cause of disability not only in the US and around the world. A total joint replacement is the standard of care..